Targeting on the PI3K/mTOR: a potential treatment strategy for clear cell ovarian carcinoma
Cancer Chemotherapy and Pharmacology · 2025
DOI: 10.1007/s00280-024-04748-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2025. Verfasst von Kewei Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, TOR Serine-Threonine Kinases, Adenocarcinoma, Clear Cell, Cisplatin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China.
- Department of Gynecology, Dalian Obstetrics and Gynecology Hospital, Dalian, 116033, China.
- Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China. yukang@fudan.edu.cn.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Zheng, K., Jin, G., Cao, R., Gao, Y., Xu, J., Chai, R., & Kang, Y. (2025). Targeting on the PI3K/mTOR: a potential treatment strategy for clear cell ovarian carcinoma. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04748-3
Vancouver
Zheng K, Jin G, Cao R, Gao Y, Xu J, Chai R, et al. Targeting on the PI3K/mTOR: a potential treatment strategy for clear cell ovarian carcinoma. Cancer Chemotherapy and Pharmacology. 2025. doi:10.1007/s00280-024-04748-3
BibTeX
@article{Zheng2025,
author = {Zheng, Kewei and Jin, Guanqin and Cao, Rui and Gao, Yi and Xu, Jing and Chai, Ranran and Kang, Yu},
title = {Targeting on the PI3K/mTOR: a potential treatment strategy for clear cell ovarian carcinoma},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2025},
doi = {10.1007/s00280-024-04748-3}
}
EUVIMED